Read the full study here #ChronicPainRelief #BackPainSupport #PainManagement #ResearchBacked #NaturalPainRelief #HolisticHealth #WellnessScience #AlternativeMedicine #ChronicBackPain #PainCare #SleepBetterLiveBetter #MobilityMatters #EvidenceBasedRelief #HolisticWellness #BackPainAwareness #ChronicPainCommunity #PainReliefJourney #ScienceInWellness #QualityOfLifeMatters #WellnessInnovation To view or add a comment, sign in Were now seeing incretin-based therapies originally developed for diabetes and obesity being studied directly in obstructive sleep apnoea (OSA)
Gmax Biopharm LLC Hanmi Pharmaceutical Co., Ltd
A key double-blind, placebo-controlled phase II study conducted over 72 weeks recruited 320 individuals with histologically confirmed NASH and liver fibrosis classified as stage F1 to F3
Flow Wellness can evaluate whether a preservative, vitamin additive, cleaning solution, or the medication itself may be contributing to your symptoms and discuss alternative options when appropriate
One older study on Byetta (exenatide) showed minimal transfer, but there are no studies on semaglutide, tirzepatide, or liraglutide in breast milk, and no data on infant outcomes when exposed via breast milk
